ArticleHaematologica2021

Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use.

Auriane Lesieur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.